18 results  1 of 1 

1 Novel therapeutics for myelofibrosis
Sung-Eun Lee
Blood Res.2023;58(S1):S13-S19.   Published online 2023 March 9     DOI: http://dx.doi.org/10.5045/br.2023.2023012
      
2 JAK2 V617F 양성 급성골수성백혈병의 임상병리학적 특징 2예
Youngeun Lee, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang, Sang Mee Hwang
Lab Med Online.2022;12(1):53-57.   Published online 2022 January 1     DOI: http://dx.doi.org/10.47429/lmo.2022.12.1.53
      
3 Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden
A-Jin Lee, Sang-Gyung Kim, Jun Yeb Nam, Jaehum Yun, Hun-Mo Ryoo, Sung Hwa Bae
Blood Res.2021;56(4):259-265.   Published online 2021 December 31     DOI: http://dx.doi.org/10.5045/br.2021.2021089
      
4 A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations
Mi-Ae Jang, Mi Yeon Seo, Kyoung Jin Choi, Dae-Sik Hong
J Korean Med Sci.2020;35(23):e168.  Published online 2020 April 27     DOI: http://dx.doi.org/10.3346/jkms.2020.35.e168
      
5 Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms
Eunyoung Lee, Kyoung Joo Lee, Hyein Park, Jin Young Chung, Mi-Na Lee, Myung Hee Chang, Jongha Yoo, Hyewon Lee, Sun-Young Kong, Hyeon-Seok Eom
Ann Lab Med.2018;38(2):147-154.   Published online 2017 December 4     DOI: http://dx.doi.org/10.3343/alm.2018.38.2.147
      
6 JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis
Bo Hyun Kim, Young-Uk Cho, Mi-Hyun Bae, Seongsoo Jang, Eul-Ju Seo, Hyun-Sook Chi, Yunsuk Choi, Dae-Young Kim, Jung-Hee Lee, Je-Hwan Lee, Kyoo-Hyung Lee, Young-Mi Park, Jong-Keuk Lee, Chan-Jeoung Park
J Korean Med Sci.2015;30(7):882-888.   Published online 2015 June 10     DOI: http://dx.doi.org/10.3346/jkms.2015.30.7.882
      
7 Frequency and Clinicohematologic Characteristics of MPL W515 Mutations in Patients with Myeloproliferative Neoplasms
Sung Gyun Park, Kyoung Bo Kim, Wonmok Lee, Jung Sook Ha, Nam Hee Ryoo, Dong Seok Jeon, Jae Ryong Kim, Ji Yeon Ham, Jang Soo Suh, Yu Kyung Kim
Lab Med Online.2015;5(1):1-1.   Published online 2015 January 1     DOI: http://dx.doi.org/10.3343/lmo.2015.5.1.1
      
8 Calreticulin Exon 9 Mutations in Myeloproliferative Neoplasms
Jung-Sook Ha, Yu-Kyung Kim
Ann Lab Med.2015;35(1):22-27.   Published online 2014 December 8     DOI: http://dx.doi.org/10.3343/alm.2015.35.1.22
      
9 A Case of Acute Myeloid Leukemia Transformed from JAK2 V617F-Positive Chronic Neutrophilic Leukemia
Jae-Hee Lee, Jung-Sook Ha, Nam-Hee Ryoo, Dong-Seok Jeon, Jae-Ryong Kim
Lab Med Online.2012;2(2):101-104.   Published online 2012 March 30     DOI: http://dx.doi.org/10.3343/lmo.2012.2.2.101
      
10 NDRG2 Promotes GATA-1 Expression through Regulation of the JAK2/STAT Pathway in PMA-stimulated U937 Cells
Kyeongah Kang, Hyeyoun Jung, Sorim Nam, Jong-Seok Lim
Immune Netw.2011;11(6):348-357.   Published online 2011 December 31     DOI: http://dx.doi.org/10.4110/in.2011.11.6.348
      
11 A Case of Atypical Chronic Myeloid Leukemia with the JAK2V617F Mutation
Ju Yeon Kim, Se Ryeon Lee, Myung-Hyun Nam, Soo-Young Yoon, Chae Seung Lim, Chang Kyu Lee, Byung Soo Kim, Yunjung Cho, Young Kee Kim, Kap No Lee
Lab Med Online.2011;1(4):232-236.   Published online 2011 October 7     DOI: http://dx.doi.org/10.3343/lmo.2011.1.4.10
      
12 JAK2 V617F and Exon 12 Genetic Variations in Korean Patients with BCR/ABL1-negative Myeloproliferative Neoplasms
Jeong Tae Kim, Yong Gon Cho, Sam Im Choi, Young Jin Lee, Hye Ran Kim, Sook Jin Jang, Dae Soo Moon, Young Jin Park, Geon Park
Korean J Lab Med.2010;30(6):567-574.   Published online 2010 December 2     DOI: http://dx.doi.org/10.3343/kjlm.2010.30.6.567
   
13 JAK2 V617F and the evolving paradigm of polycythemia vera
Robert T. Means
Korean J Hematol.2010;45(2):90-94.   Published online 2010 June 30     DOI: http://dx.doi.org/10.5045/kjh.2010.45.2.90
      
14 JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia
Dong Wook Jekarl, Sang Bong Han, Myungshin Kim, Jihyang Lim, Eun-Jee Oh, Yonggoo Kim, Hee-Je Kim, Woo-Sung Min, Kyungja Han
Korean J Hematol.2010;45(1):46-50.   Published online 2010 March 31     DOI: http://dx.doi.org/10.5045/kjh.2010.45.1.46
      
15 JAK2 V617F and MPL W515L/K Mutations in Korean Patients with Essential Thrombocythemia
Hee-Jung Kim, Ja-Hyun Jang, Eun-Hyung Yoo, Hee-Jin Kim, Chang-Seok Ki, Jong-Won Kim, Sun-Hee Kim
Korean J Lab Med.2010;30(5):474-476.   Published online 2010 January 14     DOI: http://dx.doi.org/10.3343/kjlm.2010.30.5.474
   
16 A Case of Pulmonary Thromboembolism with JAK2 Mutation
Jin-Jin Kim, Soon-Seog Kwon, Hyun-Jeong Lee, Hea-Yon Lee, Myung-Hee Jeong, Yong-Hyun Kim
Tuberc Respir Dis.2009;67(4):351-355.   Published online 2009 October 31     DOI: http://dx.doi.org/10.4046/trd.2009.67.4.351
      
17 Usefulness of Real-time Semi-quantitative PCR, JAK2 MutaScreen™ Kit for JAK2 V617F Screening
Hyojin Chae, Je-Hoon Lee, Jihyang Lim, Seung-Won Jung, Myungshin Kim, Yonggoo Kim, Kyungja Han, Byoung-Sik Cho, Seok-Goo Cho, Jong-Wook Lee, Woo-Sung Min
Korean J Lab Med.2009;29(3):243-248.   Published online 2009 January 14     DOI: http://dx.doi.org/10.3343/kjlm.2009.29.3.243
   
18 JAK2V617F Mutation in Korean Patients with Essential Thrombocythemia
Jeong-Yeal Ahn, Soo-Jin Yoo, Soo-Mee Bang, Pil-Whan Park, Yiel-Hea Seo, Dong-Bok Shin, Jae-Hoon Lee
Korean J Lab Med.2007;27(2):77-82.   Published online 2007 February 10     DOI: http://dx.doi.org/10.3343/kjlm.2007.27.2.77
   

 1 of 1